Samantha Shenoy, NP, of the UCSF Medical Center in San Francisco, California, joined Cancer Nursing Today at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition to share her experience at the meeting and key highlights. “I’m really excited to be here at ASH this year,” Shenoy said. “I’ve been attending some amazing sessions and I’ve just been amazed by all of the people that are here and the collaboration. I’ve been really enjoying, as I mentioned, some of the collaboration with colleagues such as Beth Faiman and Donna Catamero.” ...
Multiple Myeloma
Learn about the newest therapies, interventions, and clinical research on multiple myeloma (MM). Cancer Nursing Today provides the latest clinical data and insights on screening for early detection, COVID-19 vaccine responses in patients with MM, and more. From treatment developments for relapsed/refractory MM and imaging techniques to the latest in CAR T-cell therapy, explore the latest outcomes in MM.
Advertisement
Beth Faiman, PhD, MSN, APN-BC, AOCN®, BMTCN®, FAAN, FAPO, explains key takeaways from her myeloma research at ASH 2024.
Learn how oncology nurses can assess for CRS and ICANS, which are the main side effects of CAR-T and BiTE therapies.
Oncology nurses must understand how these therapies are similar but different regarding therapy-specific side effects.
An analysis presented at ASH 2024 suggests the summation of evidence supports the therapy as a new standard of care.
The implementation of the process showed that outpatient administration is safe, well-tolerated, and reduced inpatient days.
The post hoc study analysis showed that optimized bridging therapy is critical to disease control for multiple myeloma.
Researchers studied DARA plus VRd as a new standard of care vs VRd alone in patients with newly-diagnosed multiple myeloma.
The Patient Navigation Center at the Multiple Myeloma Research Foundation addresses barriers to care and supports patients.
Talquetamab showed "robust and durable responses" for patients with relapsed/refractory multiple myeloma.
Oncology nurses may be the first to identify the classic triad of hyperviscosity syndrome symptoms.
Advertisement
Trending
Studying for certification tests can be intimidating. Here are some essential tips to help you do your best.
These tips are important resources for oncology nurses who are recent graduates and experienced nurses new to this specialty.
With the shift in cancer care to the ambulatory care setting, a dedicated oncology nurse educator is a key asset to nurses.
Gastroparesis occurs in 60% of patients with advanced pancreatic cancer, and is frequently overlooked in upper GI tumors.
More unique, non-traditional jobs are emerging for oncology nurses to consider outside traditional positions.
Alkaline phosphatase may serve as a discriminating marker in detecting bone lesions in patients with multiple myeloma.
Advertisement
Expert Contributor
Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®Elaine S. DeMeyer, RN, MSN, AOCN®, BMTCN®, is the owner of beyond Oncology Education, LLC.
Advertisement
Latest News
Learn how a research team created a nurse-led insomnia intervention for survivors of cancer.
Oncology nurses play a vital role in identifying the signs of treatment-related angiosarcoma during survivorship care.
Theresa Brown, RN, weighs in on the public reaction to the shooting of United Healthcare CEO Brian Thompson.
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.